Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and pan-PPAR partial agonists.
Thiazolidinediones (TZDs) act through peroxisome proliferator activated receptor (PPAR) γ to increase insulin sensitivity in type 2 diabetes (T2DM), but deleterious effects of these ligands mean that selective modulators with improved clinical profiles are needed. We obtained a crystal structure of...
Main Authors: | Marcelo Vizoná Liberato, Alessandro S Nascimento, Steven D Ayers, Jean Z Lin, Aleksandra Cvoro, Rodrigo L Silveira, Leandro Martínez, Paulo C T Souza, Daniel Saidemberg, Tuo Deng, Angela Angelica Amato, Marie Togashi, Willa A Hsueh, Kevin Phillips, Mário Sérgio Palma, Francisco A R Neves, Munir S Skaf, Paul Webb, Igor Polikarpov |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3359336?pdf=render |
Similar Items
-
The Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Pan-Cancer
by: Runzhi Huang, et al.
Published: (2020-01-01) -
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
by: Nordsletten Lars, et al.
Published: (2009-03-01) -
Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptors.
by: Li-Song Zhang, et al.
Published: (2012-01-01) -
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
by: Tenenbaum Alexander, et al.
Published: (2005-09-01) -
Peroxisome Proliferators Activated Receptor (PPAR) agonists activate hepatitis B virus replication in vivo
by: Lingyao Du, et al.
Published: (2017-05-01)